ENTAEnanta Pharmaceuticals, Inc.

$12.10+9.2% 1Y

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk91% volderived · Oct 8, 2026

Large price swings, high volatility. Worst drawdown -97% · now 28% below its 52-week high.

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can ENTA take a bad year?

The deepest fall in ENTA's price history on file is −97%; it is 28% below its high today.

−97%

Worst drawdown on file · −28% today

Cash runway
5+ years

Cash runway · burning $9.2M a quarter at the current rate

Annualised volatility
91%

Annualised volatility · three times the market's own swing

Details›
Cash and short-term investments
$190M
EBITDA, trailing twelve months
−$54M
Operating profit, trailing twelve months
−$59M
Annualised volatilitytwo years of daily moves
91%
Worst drawdown on file
−97%
Below its 52-week high
28%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.